3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
7
Multiple Myeloma
5
Squamous Cell Carcinoma of Head and Neck
2
Peripheral Nervous System Diseases
2
Oropharyngeal Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Vomiting
1
Urinary Bladder Neoplasms
1
Tongue Neoplasms
1
Stomach Neoplasms
1
Sleep Initiation and Maintenance Disorders
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Hyperplasia
1
Pancreatic Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Nasopharyngeal Neoplasms
1
Myasthenia Gravis
1
Mucositis
1
Lymphoma, Follicular
1
Lymphedema
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Gastro-enteropancreatic neuroendocrine tumor
1
Esthesioneuroblastoma, Olfactory
1
Interventions
Cisplatin
32
human papillomavirus vaccine, L1 type 16, 18
16
Brachytherapy
15
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
12
Paclitaxel
11
Bevacizumab
11
pembrolizumab
10
Platinum
9
1,2-diaminocyclohexaneplatinum II citrate
9
Topotecan
8
Radiotherapy, Intensity-Modulated
8
Radiation
8
Papillomavirus Vaccines
8
atezolizumab
6
Gemcitabine
6
Fluorodeoxyglucose F18
6
Cyclophosphamide
6
tisotumab vedotin
5
fludarabine phosphate
5
fludarabine
5
aldesleukin
5
Taxes
5
Radiotherapy
5
Magnetic Resonance Spectroscopy
5
Carboplatin
5
Vaccines, Synthetic
4
Nivolumab
4
Immunoglobulin G
4
Disulfides
4
Colposcopy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Uterine Cervical Neoplasms
×
Acupuncture Therapy
×
Clear all
No trials found.